2020-04-24T12:07:00+10:00 : It was a BS Chinese trial, which they stopped because they “couldn’t get enough patients”, meanwhile they were trying to patent the drug themselves.Anyone selling on this news will be sorely disappointed, word from US doctors and hospitals is that it’s a winner. Wait for the US results at the end of next week.